Investors & Media

Stock Info

News Releases

October 3, 2024Annovis Bio Inc. (NYSE: ANVS) Leading Way in Development of Safe, Effective Drugs for Neurodegenerative Diseases
October 2, 2024Annovis Bio Inc. (NYSE: ANVS) Research Points to Potential Future Breakthroughs in AD Space Through Innovative Combinations
September 30, 2024Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and Viagra

MORE NEWS RELEASES

Events & Presentations

Heading

Annovis Bio - Phase III PD Data

View Webcast
Heading

AD & PD Data Updates - July 2024

Filings

For Year:

Filing Type:

Keyword search:

Records per Page:

8-K

Current report filing

Sep 30, 2024

Format Format Format Format Format Format Format

8-K

Current report filing

Aug 15, 2024

Format Format Format Format Format Format Format

10-Q

Quarterly Report

Aug 14, 2024

Format Format Format Format Format Format Format Format

8-K

Current report filing

Aug 06, 2024

Format Format Format Format Format Format Format

8-K

Current report filing

Jul 16, 2024

Format Format Format Format Format Format Format

8-K

Current report filing

Jul 10, 2024

Format Format Format Format Format Format Format

4

Statement of Changes in Beneficial Ownership

Jul 03, 2024

Format Format Format Format Format Format

4

Statement of Changes in Beneficial Ownership

Jul 03, 2024

Format Format Format Format Format Format

4

Statement of Changes in Beneficial Ownership

Jul 03, 2024

Format Format Format Format Format Format

4

Statement of Changes in Beneficial Ownership

Jul 03, 2024

Format Format Format Format Format Format

«
1
2
3
4
5
...
21
22
»

Investors

Stock Info

News Releases

Events & Presentations

Heading

Annovis Bio - Phase III PD Data

Heading

AD & PD Data Updates - July 2024

Filings

Corporate Governance

E-mail Alerts

Alert Categories